z-logo
open-access-imgOpen Access
Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27
Author(s) -
JudithAnne W. Chapman,
Lois E. Shepherd,
James N. Ingle,
Hyman B. Muss,
Kathleen I. Pritchard,
Karen A. Gelmon,
Timothy J. Whelan,
Catherine Elliott,
Paul E. Goss
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/k0er-5480
Subject(s) - aromatase , medicine , breast cancer , adjuvant , aromatase inhibitor , oncology , gynecology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom